Novel Physical Therapist Lens on Developing a SARS-CoV-2 Vaccine: “Healthy Lifestyle Practices” Are Safe and Cost-Effective

E. Dean
{"title":"Novel Physical Therapist Lens on Developing a SARS-CoV-2 Vaccine: “Healthy Lifestyle Practices” Are Safe and Cost-Effective","authors":"E. Dean","doi":"10.1097/cpt.0000000000000157","DOIUrl":null,"url":null,"abstract":"Once the SARS-CoV-2 virus hit the planet in the fall of 2019 and an understanding of its infectiousness and severity quickly became apparent, the starting gun in the race for a vaccine sounded. The trajectory for vaccine development follows a typical path: the identification of a specific pathogen, deconstruction of its structural characteristics, construction of a vaccine to counter it, and years of phased clinical trials to establish its safety, efficacy, and eventual effectiveness when administered to humans. Correspondingly, as the race for a vaccine escalated, research emerged examining susceptibility and risk factors for poor outcomes of COVID-19, the disease caused by SARS-CoV-2. Based on the concurrence of findings from multiple studies that were being published at a feverish rate, a pattern arose. Multimorbidity including obesity, hypertension, diabetes, cancer, heart disease, chronic lung disease, and renal failure; aging; and frailty emerged as key predictors of susceptibility and poor outcomes of COVID-19 includingmortality. Between 96% and 99% of individuals who die from SARS-CoV-2 infection have at least one underlying chronicmorbidity or risk factor. This proportion cannot be overlooked. Not only are physical therapists well qualified to prevent as well as manage these morbidities and risk factors, but the cardiopulmonary physical therapy community has a primary responsible to lead the way. Vaccines not only take years to formulate and test before becoming widely available and distributed, but typically have variable rates of effectiveness. This is particularly true of viruses that adapt and mutate quickly. The earliest predictions for the development of a safe and reasonably effective vaccine may be several years. But, what if we shifted our lens on conceptualizing and developing a safe and effective vaccine?What if we focused on the immune status, general health status, and lifestyle practices of those who are uninfected by SARS-CoV-2; those who are infected but experience few, if any, symptoms; and those who are infected and have severe symptoms and recover? What if we stratified these 3 cohorts and compared them with respect to their immune status, their general health status, and lifestyle practices? Based on the extant literature, such an analysis leads one to reasonably hypothesize whether the reach of SARS-CoV-2 would have resulted in being a mere blip on the global health radar screen rather than a full-blown pandemic, had unhealthy lifestyle practices, that largely underlie the prevalence of lifestyle-related noncommunicable diseases, been minimal. One cannot deny that the food industry (perhaps better termed the “edible products” industry) in high-income countries and increasingly in middle-income and lowincome countries, contributes substantially to the unhealthy western diet that typically consists of excessive amounts of fat, sugar, salt, and consumable processed products and dangerously inadequate amounts of vegetables, fruit, legumes, and whole grains. A whole-food plant-based diet has been well documented to be both healthful and disease preventive. With globalization, the western diet has itself become pandemic along with other unhealthy practices such as prolonged sitting, inadequate physical activity, and smoking. Thus, it is not inconceivable that these practices increase susceptibility to infective viral load given they have beenwell established to be proinflammatory by exacerbating the inflammatory response. A viral load superimposed on such chronic lower-grade systemic inflammation warrants being a research priority particularly in light of COVID-19. Adopting and adhering to healthy lifestyle practices— known to be anti-inflammatory—is safe, effective, can be instituted immediately, and yields such positive effects as reduced blood pressure, blood sugar, and body weight relatively quickly and even show signs of reversing atherosclerosis within a year or so. To implement safe and effective protection against SARS-CoV-2 infection and help minimize its susceptibility, healthy lifestyle practices including wholefood plant-based nutrition and physical activity, we as the leading established noninvasive (i.e., nondrug and nonsurgical) health profession in the world, need not only to address the root of the problem and support responsible evidence-based practice in addressing it but also assume a","PeriodicalId":72526,"journal":{"name":"Cardiopulmonary physical therapy journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiopulmonary physical therapy journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/cpt.0000000000000157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Once the SARS-CoV-2 virus hit the planet in the fall of 2019 and an understanding of its infectiousness and severity quickly became apparent, the starting gun in the race for a vaccine sounded. The trajectory for vaccine development follows a typical path: the identification of a specific pathogen, deconstruction of its structural characteristics, construction of a vaccine to counter it, and years of phased clinical trials to establish its safety, efficacy, and eventual effectiveness when administered to humans. Correspondingly, as the race for a vaccine escalated, research emerged examining susceptibility and risk factors for poor outcomes of COVID-19, the disease caused by SARS-CoV-2. Based on the concurrence of findings from multiple studies that were being published at a feverish rate, a pattern arose. Multimorbidity including obesity, hypertension, diabetes, cancer, heart disease, chronic lung disease, and renal failure; aging; and frailty emerged as key predictors of susceptibility and poor outcomes of COVID-19 includingmortality. Between 96% and 99% of individuals who die from SARS-CoV-2 infection have at least one underlying chronicmorbidity or risk factor. This proportion cannot be overlooked. Not only are physical therapists well qualified to prevent as well as manage these morbidities and risk factors, but the cardiopulmonary physical therapy community has a primary responsible to lead the way. Vaccines not only take years to formulate and test before becoming widely available and distributed, but typically have variable rates of effectiveness. This is particularly true of viruses that adapt and mutate quickly. The earliest predictions for the development of a safe and reasonably effective vaccine may be several years. But, what if we shifted our lens on conceptualizing and developing a safe and effective vaccine?What if we focused on the immune status, general health status, and lifestyle practices of those who are uninfected by SARS-CoV-2; those who are infected but experience few, if any, symptoms; and those who are infected and have severe symptoms and recover? What if we stratified these 3 cohorts and compared them with respect to their immune status, their general health status, and lifestyle practices? Based on the extant literature, such an analysis leads one to reasonably hypothesize whether the reach of SARS-CoV-2 would have resulted in being a mere blip on the global health radar screen rather than a full-blown pandemic, had unhealthy lifestyle practices, that largely underlie the prevalence of lifestyle-related noncommunicable diseases, been minimal. One cannot deny that the food industry (perhaps better termed the “edible products” industry) in high-income countries and increasingly in middle-income and lowincome countries, contributes substantially to the unhealthy western diet that typically consists of excessive amounts of fat, sugar, salt, and consumable processed products and dangerously inadequate amounts of vegetables, fruit, legumes, and whole grains. A whole-food plant-based diet has been well documented to be both healthful and disease preventive. With globalization, the western diet has itself become pandemic along with other unhealthy practices such as prolonged sitting, inadequate physical activity, and smoking. Thus, it is not inconceivable that these practices increase susceptibility to infective viral load given they have beenwell established to be proinflammatory by exacerbating the inflammatory response. A viral load superimposed on such chronic lower-grade systemic inflammation warrants being a research priority particularly in light of COVID-19. Adopting and adhering to healthy lifestyle practices— known to be anti-inflammatory—is safe, effective, can be instituted immediately, and yields such positive effects as reduced blood pressure, blood sugar, and body weight relatively quickly and even show signs of reversing atherosclerosis within a year or so. To implement safe and effective protection against SARS-CoV-2 infection and help minimize its susceptibility, healthy lifestyle practices including wholefood plant-based nutrition and physical activity, we as the leading established noninvasive (i.e., nondrug and nonsurgical) health profession in the world, need not only to address the root of the problem and support responsible evidence-based practice in addressing it but also assume a
物理治疗师开发严重急性呼吸系统综合征冠状病毒2型疫苗的新视角:“健康生活方式”安全且经济高效
一旦严重急性呼吸系统综合征冠状病毒2型病毒在2019年秋天袭击地球,人们对其传染性和严重性的了解很快变得明显,疫苗竞赛的发令枪就响了。疫苗开发的轨迹遵循一条典型的路径:识别特定病原体,解构其结构特征,构建对抗它的疫苗,以及多年的分阶段临床试验,以确定其对人类的安全性、有效性和最终有效性。相应地,随着疫苗竞赛的升级,出现了研究新冠肺炎不良后果的易感性和风险因素的研究,这是一种由SARS-CoV-2引起的疾病。基于以狂热的速度发表的多项研究结果的一致性,出现了一种模式。多发病,包括肥胖、高血压、糖尿病、癌症、心脏病、慢性肺病和肾衰竭;变老和虚弱成为新冠肺炎易感性和不良结局(包括死亡率)的关键预测因素。96%至99%死于严重急性呼吸系统综合征冠状病毒2型感染的人至少有一种潜在的慢性发病率或风险因素。这一比例不容忽视。物理治疗师不仅有资格预防和管理这些疾病和风险因素,而且心肺物理治疗社区也负有主要责任。疫苗在广泛提供和分发之前,不仅需要数年的时间来制定和测试,而且通常具有可变的有效率。对于适应和变异迅速的病毒来说尤其如此。开发安全、合理有效的疫苗的最早预测可能需要几年时间。但是,如果我们把目光转移到概念化和开发安全有效的疫苗上会怎么样?如果我们关注那些未感染严重急性呼吸系统综合征冠状病毒2型的人的免疫状态、总体健康状况和生活方式,会怎么样;那些被感染但症状很少(如果有的话)的人;以及那些被感染并出现严重症状并康复的人?如果我们对这3个队列进行分层,并根据他们的免疫状态、总体健康状况和生活方式进行比较,会怎么样?根据现有文献,这样的分析可以合理地假设,严重急性呼吸系统综合征冠状病毒2型的传播范围是否会导致全球健康雷达屏幕上的一个光点,而不是一场全面的流行病,是否有不健康的生活方式,这在很大程度上是生活方式相关非传染性疾病流行的基础,是最小的。人们不能否认,在高收入国家以及越来越多的中等收入和低收入国家,食品行业(也许更好地称为“可食用产品”行业)对不健康的西方饮食做出了重大贡献,这种饮食通常包括过量的脂肪、糖、盐和可消费的加工产品,豆类和全谷物。全食物植物性饮食已被充分证明是健康和预防疾病的。随着全球化,西方饮食本身已经成为流行病,还有其他不健康的做法,如久坐、体育活动不足和吸烟。因此,这些做法增加了对感染性病毒载量的易感性,这并非不可想象,因为它们已经被证明是通过加剧炎症反应来促炎的。病毒载量叠加在这种慢性低级别全身炎症上,尤其是在新冠肺炎的情况下,有必要成为研究的优先事项。采用和坚持健康的生活方式——众所周知是抗炎的——是安全、有效的,可以立即开始,并能相对较快地产生降压、血糖和体重等积极作用,甚至在一年左右的时间内显示出逆转动脉粥样硬化的迹象。为了实施安全有效的预防严重急性呼吸系统综合征冠状病毒2型感染的保护措施,并帮助最大限度地减少其易感性,我们作为世界上领先的非侵入性(即非药物和非手术)健康专业人士,不仅需要解决问题的根源,支持负责任的循证实践来解决问题,而且还需要承担
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信